Tilray Brands, Inc. (TLRY)
NASDAQ: TLRY · Real-Time Price · USD
2.930
+0.010 (0.34%)
At close: Oct 22, 2026, 4:00 PM EDT
2.930
0.00 (0.00%)
Pre-market: Oct 23, 2026, 4:25 AM EDT

Tilray Brands Revenue

Tilray Brands had revenue of $257.15M in the quarter ending August 31, 2026, with 22.74% growth. This brings the company's total for the last twelve months to $963.10M, up 15.93% year-over-year. In the fiscal year ending May 31, 2026, Tilray Brands had annual revenue of $915.45M with 11.46% growth. That makes Tilray Brands the 7,772nd largest company in the world by revenue and 1,814th in the United States.

Revenue (ttm)
$963.10M
Revenue Growth
+15.93%
P/S Ratio
0.45
Revenue / Employee
$267,900
Employees
3,595
Market Cap
429.72M

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Distribution 327.24M 35.7%
  • Cannabis 268.34M 29.3%
  • Beverage 253.98M 27.7%
  • Wellness 65.89M 7.2%

By Geography

Chart
  • EMEA 445.70M 48.7%
  • USA 242.39M 26.5%
  • Canada 215.66M 23.6%
  • Rest of World 11.71M 1.3%
Fiscal year ended May 31, 2026 See the full Tilray Brands breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
May 31, 2026915.45M94.15M11.46%
May 31, 2025821.31M32.37M4.10%
May 31, 2024788.94M161.82M25.80%
May 31, 2023627.12M-1.25M-0.20%
May 31, 2022628.37M115.29M22.47%
May 31, 2021513.09M302.60M143.77%
Dec 31, 2020210.48M-194.84M-48.07%
May 31, 2020405.33M238.35M142.74%
Dec 31, 2019166.98M123.85M287.15%
Dec 31, 201843.13M22.59M110.00%
Dec 31, 201720.54M7.89M62.43%
Dec 31, 201612.64M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Evotec SE819.47M
Emergent BioSolutions770.20M
Ironwood Pharmaceuticals389.32M
Evolus316.49M
Aurora Cannabis221.16M
Canopy Growth206.77M
Kamada191.85M
Anika Therapeutics120.65M
Revenue Rankings